In their study, Zheng and his team discovered that hepatic HSP90β, rather than HSP90α, was increased in both individuals with nonalcoholic fatty liver disease (NAFLD) and obese mice. This evidence concerns the gene HSP90AB1 and metabolic dysfunction-associated steatotic liver disease.